Literature DB >> 21487417

Targeted therapies: chemotherapy-free option for relapsed patients with breast cancer.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2011        PMID： 21487417     DOI： 10.1038/nrclinonc.2011.55

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03).

Authors:  D Koeberle; T Ruhstaller; L Jost; O Pagani; K Zaman; R von Moos; C Oehlschlegel; S Crowe; C Pilop; B Thuerlimann
Journal:  Endocr Relat Cancer       Date:  2011-03-09       Impact factor: 5.678
  1 in total
  1 in total

Review 1.  Molecular prescreening to select patient population in early clinical trials.

Authors:  Jordi Rodón; Cristina Saura; Rodrigo Dienstmann; Ana Vivancos; Santiago Ramón y Cajal; José Baselga; Josep Tabernero
Journal:  Nat Rev Clin Oncol       Date:  2012-04-03       Impact factor: 66.675
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.